We’re excited to feature Dr. Arndt Vogel, a distinguished leader in gastrointestinal cancer research and treatment, as our next oncoinfluencer.
About Arndt Vogel
Arndt Vogel, MD, is a Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. Leading the GI-Cancer Center and the Center for Personalized Medicine, his research focuses on translational and clinical studies in gastrointestinal cancer. He’s actively engaged in various societies including ESMO, ASCO, and EASL. Additionally, he chairs the Hepatobiliary Cancer Study Group of the AIO, contributing significantly to clinical oncology in Germany. Within ESMO, he serves on the Guidelines Steering Committee.
Dr. Arndt Vogel is an active presence on social media, regularly sharing his expertise on gastrointestinal cancer treatment, emerging clinical trials, and advancements in personalized medicine. His posts on X/Twitter and LinkedIn offer valuable updates on the latest breakthroughs in GI cancer research, hepatobiliary malignancies, and the future of cancer care.
Follow Dr. Arndt Vogel on X/Twitter and LinkedIn to stay updated on his pioneering research and contributions to the field of gastrointestinal oncology.
Stay tuned for more OncoInfluencers and check out previous profiles on our website to discover other influential voices in the oncology community.